Structural imaging remains an essential component of diagnosis, staging and response
assessment in patients with cancer; however, as clinicians increasingly seek to …

Purpose The specific indications of somatostatin analogs (SSAs) in patients with
neuroendocrine tumor (NET) emerged over the time. The objective of this review is to …

Simple Summary Cytotoxic chemotherapy is a standard therapy for patients with poorly
differentiated neuroendocrine carcinomas, however, its role in patients with well …

As the incidence of neuroendocrine tumors has been rising, gender differences in
epidemiology and clinical behavior have emerged, and interest into a gender-driven …

This paper is the first of a Series on theranostics that summarises the current landscape of
the radiopharmaceutical sciences as they pertain to oncology. In this Series paper, we …

Radioiodine-refractory differentiated thyroid cancer (RAIR-DTC), though uncommon,
presents a considerable therapeutic challenge with poor long-term outcomes. Currently …

Peptide receptor chemoradionuclide therapy (PRCRT), the addition of radiosensitising
chemotherapy to peptide receptor radionuclide therapy (PRRT), has been used in individual …

Background Recent advances in the management of pancreatic neuroendocrine tumors
(pNETs) highlight the potential benefits of temozolomide, an alkylating agent, for these …

Gastro-enteric-pancreatic neuroendocrine tumors (GEP-NETs), although a rare group of
tumors, have shown a rising burden over the decades, with the age-adjusted incidence rate …

Safety and Efficacy of 177Lu-DOTATATE in Children and Young... : Clinical Nuclear Medicine
Safety and Efficacy of 177Lu-DOTATATE in Children and Young Adult Population: A …